XML 58 R48.htm IDEA: XBRL DOCUMENT
v3.22.2.2

INVESTMENTS IN EQUITY SECURITIES (Details Narrative) - USD ($) |  |  |  | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 17, 2021 | Jun. 03, 2021 | Nov. 09, 2020 | Mar. 31, 2022 | Dec. 31, 2021 | Oct. 31, 2021 | Feb. 28, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | Jun. 30, 2021 | Jul. 31, 2020
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long term investments |  |  |  |  | $ 5,017,351 |  |  | $ 3,084,278 |  |  | $ 3,084,278 |  | $ 5,017,351 |  |
Value of shares purchased |  |  |  |  |  |  |  |  |  | $ 28,939,257 |  |  |  |  |
Investments |  |  |  |  | $ 5,017,351 |  |  | 3,084,278 |  |  | 3,084,278 |  | $ 5,017,351 |  |
Loss on equity method investment |  |  |  |  |  |  |  |  | $ 193,843 |  | 379,633 | $ 472,747 |  |  |
Precision Healing Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss on equity method investment |  |  |  |  |  |  |  |  | $ 193,843 |  | $ 379,633 | $ 472,747 |  |  |
Series B 2 Preferred Shares [Member] | Direct Derm's [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest |  |  |  |  |  |  |  | 8.10% |  |  | 8.10% |  |  |  | 2.90%
Series A Convertible Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest |  |  | 12.60% |  |  |  |  |  |  |  |  |  |  |  |
Series A Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest | 29.00% |  |  |  |  |  | 22.40% |  |  |  |  |  |  |  |
Class A Preferred Shares [Member] | Pixalere Healthcare Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest |  |  |  |  |  |  |  |  |  |  |  |  |  | 27.30% |
Series B 2 Preferred Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long term investments |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 500,000
Marketable securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 7,142,857
Series B 2 Preferred Shares [Member] | Direct Derm's [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of additional shares |  |  |  | 3,571,429 |  |  |  |  |  |  |  |  | 3,571,430 |  |
Value of shares purchased |  |  |  | $ 250,000 |  |  |  |  |  |  |  |  | $ 250,000 |  |
Series A Convertible Preferred Stock [Member] | Precision Healing Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of additional shares |  |  | 150,000 |  |  |  |  |  |  |  |  |  |  |  |
Value of shares purchased |  |  | $ 600,000 |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock |  |  | 150,000 |  |  |  |  |  |  |  |  |  |  |  |
Series A Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of additional shares | 125,000 |  |  |  | 150,000 | 125,000 | 150,000 |  |  |  |  |  |  |  |
Value of shares purchased |  |  |  |  | $ 600,000 | $ 500,000 |  |  |  |  |  |  |  |  |
Investments | $ 500,000 |  |  |  |  |  | $ 600,000 |  |  |  |  |  |  |  |
Series A Stock [Member] | Precision Healing Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock |  |  |  |  |  |  | 150,000 |  |  |  |  |  |  |  |
Class A Preferred Shares [Member] | Pixalere Healthcare Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of Investments [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of additional shares |  | 278,587 |  |  |  |  |  |  |  |  |  |  |  |  |
Investments |  | $ 2,084,278 |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  | 27.30% |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership amount |  | $ 93,879 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586 + Details
Name: | us-gaap_ConversionOfStockSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586 + Details
Name: | us-gaap_DebtConversionConvertedInstrumentRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents the aggregate cost of investments accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_EquityMethodInvestmentAggregateCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.1(h)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_Investments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(12)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_LongTermInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in marketable security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.4) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 + Details
Name: | us-gaap_MarketableSecurities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=SMTI_PrecisionHealingIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=SMTI_SeriesBTwoPreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=SMTI_DirectDermsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=SMTI_SeriesAConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=SMTI_SeriesAStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=SMTI_ClassAPreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=SMTI_PixalereHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=SMTI_SeriesBTwoPreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=SMTI_SeriesAConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=SMTI_SeriesAStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=SMTI_ClassAPreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |